MGC Pharmaceuticals
14stories
MGC Pharmaceuticals · page 2
- Press releases
First CannEpil delivered to UK patients through I AM Billy Foundation and GMC Specialist Register
MGC Pharmaceuticals Ltd (“MGC Pharma”, “MGC” or the “Company”) a European based pharmaceutical company specialising in the production and development of plant inspired medicines, is pleased to announce that CannEpil®, MGC Pharma’s IMP has now been successfully imported and received by its first patients in the United Kingdom.
- Press releases
MGC Pharmaceuticals Ltd Announces Completion Of CimetrA Mechanism Of Action Study
PRESS RELEASE Key Highlights: MGC Pharma has completed an in-vitro pre-clinical study on CimetrA™’s mechanism of action (MoA) The study, which was carried out at the GLP-Certified Science in Action Lab, in Ness Ziona, Israel, examined the mechanism underlying the CimetrA™-mediated anti-inflammatory effect on human Peripheral Blood Mononuclear Cells (PBMC) The study demonstrated the inhibitory…
